S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Avoro Capital Advisors/Q2 2023

Avoro Capital Advisors

Periodo: Q2 2023 Β· Depositato: 2023-08-14
Vedi su SEC EDGAR β†—
AUM
$7.37B
Valore totale del portafoglio
Posizioni
43
Titoli dichiarati
Prima Posizione
APLS
13.7% $1.01B
Var. Trimestrali
+6 / -2
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2023-08-14) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
APLSAPELLIS PHARMACEUTICALS INC$1.01B13.73%$91.10β€”
13.7%
HZNPHORIZON THERAPEUTICS PLC$720.0M9.77%β€”β€”
9.8%
UTHRUNITED THERAPEUTICS CORP$642.4M8.71%$220.75$555.91+151.8%
8.7%
SRPTSAREPTA THERAPEUTICS INC$530.0M7.19%$114.52$19.28-83.2%
7.2%
ARGXARGENX SE$492.4M6.68%$389.73$939.68+141.1%
6.7%
MDGLMADRIGAL PHARMACEUTICALS INC$350.0M4.75%$231.00$528.10+128.6%
4.8%
BMRNBIOMARIN PHARMACEUTICAL INC$346.7M4.70%$86.68$58.99-31.9%
4.7%
FOLDAMICUS THERAPEUTICS INC$344.1M4.67%β€”β€”
4.7%
SGENSEAGEN INC$338.6M4.59%β€”β€”
4.6%
ASNDASCENDIS PHARMA$319.6M4.34%$89.25$274.50+207.6%
4.3%
ISEEIVERIC BIO INC$316.7M4.30%β€”β€”
4.3%
KRYSKRYSTAL BIOTECH INC$300.6M4.08%$117.40$375.07+219.5%
4.1%
ALNYALNYLAM PHARMACEUTICALS INC$209.9M2.85%$189.94$312.78+64.7%
2.9%
MRTXMIRATI THERAPEUTICS INC$200.7M2.72%β€”β€”
2.7%
XENEXENON PHARMACEUTICALS INC$188.7M2.56%$38.50$60.96+58.3%
2.6%
CBAYCYMABAY THERAPEUTICS INC$112.8M1.53%β€”β€”
1.5%
DICEDICE THERAPEUTICS INC$102.2M1.39%β€”β€”
1.4%
KYMRKYMERA THERAPEUTICS INC$88.6M1.20%$22.99$113.51+393.7%
1.2%
MLTXMOONLAKE IMMUNOTHERAPEUTICS$88.0M1.19%$51.00$18.95-62.8%
1.2%
BCRXBIOCRYST PHARMACEUTICALS INC$84.9M1.15%$7.04$9.84+39.8%
1.1%
NUVLNUVALENT INC$67.5M0.92%$42.17$123.73+193.4%
0.9%
ROIVROIVANT SCIENCES LTD$58.5M0.79%$10.08$35.13+248.5%
0.8%
SNDXSYNDAX PHARMACEUTICALS INC$55.5M0.75%$20.93$21.82+4.3%
0.8%
IOVAIOVANCE BIOTHERAPEUTICS INC$47.2M0.64%$7.04$4.31-38.8%
0.6%
MNKDMANNKIND CORP$37.0M0.50%$4.07$4.52+11.1%
0.5%
RAREULTRAGENYX PHARMACEUTICAL INC$34.6M0.47%$46.13$33.47-27.4%
0.5%
MRNSMARINUS PHARMACEUTICALS INC$34.2M0.46%β€”β€”
0.5%
KURAKURA ONCOLOGY INC$32.9M0.45%$10.58$11.10+4.9%
0.5%
GLUEMONTE ROSA THERAPEUTICS INC$31.1M0.42%$6.85$24.21+253.4%
0.4%
RNAMAVIDITY BIOSCIENCES INC$27.8M0.38%β€”β€”
0.4%

AttivitΓ  Trimestre su Trimestre

Q2 2023 vs. Q1 2023

Nuove Posizioni (6)

TickerEmittenteNozionaleDal Deposito
MLTXMOONLAKE IMMUNOTHERAPEUTICS$88.0M-62.8%
ROIVROIVANT SCIENCES LTD$58.5M+248.5%
ARWRARROWHEAD PHARMACEUTICALS INC$12.7M
IKNAIKENA ONCOLOGY INC$10.8M
TALSTALARIS THERAPEUTICS INC$1.5M
AGLEAEGLEA BIOTHERAPEUTICS INC$0.1M

Posizioni Chiuse (2)

TickerEmittenteNozionale
AMLXAMYLYX PHARMACEUTICALS INC$13.9M
XBISPDR SERIES TRUST - S&P BIOTECH$0.2M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
SRPTSAREPTA THERAPEUTICS INC$526.3M+1751.2%-83.2%
ISEEIVERIC BIO INC$314.9M+820.0%
MCRBSERES THERAPEUTICS INC$4.6M+93.1%
KRYSKRYSTAL BIOTECH INC$160.5M+46.3%+219.5%
SRPTSAREPTA THERAPEUTICS INC$26.9M+26.8%-83.2%
ISEEIVERIC BIO INC$151.2M+18.4%
BCRXBIOCRYST PHARMACEUTICALS INC$-2.0M+15.7%+39.8%
VRCAVERRICA PHARMACEUTICALS INC$-0.2M+11.5%

Ridotte (7)

TickerEmittenteNozionaleVar. AzioniDal Deposito
DICEDICE THERAPEUTICS INC$-11.0M-44.3%
MRSNMERSANA THERAPEUTICS INC$-10.1M-15.6%
NUVLNUVALENT INC$18.2M-15.3%+193.4%
MDGLMADRIGAL PHARMACEUTICALS INC$-53.8M-9.1%+128.6%
IOVAIOVANCE BIOTHERAPEUTICS INC$4.3M-4.6%-38.8%
SGENSEAGEN INC$-26.2M-2.3%
ARGXARGENX SE$12.7M-1.9%+141.1%
← Torna agli Hedge Fund